RGLS insider trading
Regulus Therapeutics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
RGLS insider activity at a glance
FilingIQ has scored 208 insider transactions for RGLS since Jan 28, 2015. The most recent filing in our index is dated Jun 25, 2025.
Across the full history, 50 open-market purchases
and 54 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RGLS insider trades is 62.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RGLS Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Frequently asked
- How many insider trades does FilingIQ track for RGLS?
- FilingIQ tracks 208 Form 4 insider transactions for RGLS (Regulus Therapeutics Inc.), covering filings from Jan 28, 2015 onwards. 0 of those were filed in the last 90 days.
- Are RGLS insiders net buyers or net sellers?
- Across the full Form 4 history for RGLS, 50 transactions (24%) were open-market purchases and 54 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RGLS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
Methodology & sources
Every RGLS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.